Abstract
Estrogen (E2), acting via its nuclear receptors, has been implicated in tumor development and growth, particularly in the pathogenesis of breast cancer. E2 also modulates anterior pituitary hormone production and is a potent cell mitogen. Until recently, the actions of E2 were thought to be mediated by a single estrogen receptor (ER) isoform (ERα), and currently little is known of the pathophysiological relevance of the ERβ isoform. The presence of ERβ mRNA has been demonstrated by RT-PCR in the normal human pituitary, although expression of ERβ mRNA in human pituitary tumors has not been described. We have used semiquantitative RT-PCR to determine the relative levels of expression of ERβ mRNA in normal human pituitaries, non-functioning pituitary adenomas and GH-secreting tumors. ERβ mRNA was detected in normal pituitaries and all pituitary tumors examined. The ratio of ERβ mRNA to β-actin mRNA expression was significantly reduced in non-functioning pituitary tumors (NFTs; 0.92 ± 0.09; mean ± SE; n=23) compared with findings in normal pituitaries (1.56 ± 0.21; mean ± SE; n=5; p<0.05 Student's t-test). Studies of ERβ protein expression are required to determine the functional significance of reduced ERβ mRNA expression in NFTs.
Similar content being viewed by others
References
Kineman RD, Faught WJ, Frawley LS. Steroids can modulate transdifferentiation of prolactin and growth hormone cells in bovine pituitary cultures. Endocrinol 1992;130: 3289-3294.
Scully KM, A. S. G, Lindzey J, Lubahn DB, Korach KS, Rosenfeld MG. Role of estrogen receptor-alpha in the anterior pituitary gland. Mol Endocrinol 1997;11:674-681.
Furth J. Experimental pituitary tumors. Recent rog Hormone Res 1955;11:221-249.
Lieberman ME, Maurer RA, Claude P, Wiklund J. N. W, Gorski J. Regulation of pituitary growth and prolactin gene expression by estrogen, hormones and cancer. In: Leavitt WW, ed. Hormones and cancer. New York: Plenum Press, 1980:151-163.
Lloyd RV. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. Am J Pathol 1983;113: 198-206.
Lloyd RV, Jin L, Fields K, Kulig E. Effects of estrogens on pituitary cell and pituitary tumor growth. [Review] [30 refs]. Pathology, Research & Practice 1991;187: 584-586.
Ponglikitmongkol M, Green S, Chambon P. Genomic organization of the human oestrogen receptor gene. Embo J 1988;7:3385-3388.
Mosselman S, Polman J, Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. Febs Lett 1996;392:49-53.
Chaidarun SS, Klibanski A, Alexander JM. Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas. J Clin Endocrinol Metab 1997;82:1058-1065.
Petersen DN, Tkalcevic GT, Koza-Taylor PH, Turi TG, Brown TA. Identification of estrogen receptor β2, a functional variant of estrogen receptor β expressed in normal rat tissues. Endocrinol 1998;139:1082-1092.
Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lupu R. Expression of estrogen receptor beta messenger RNA variant in breast cancer. Cancer Res 1998;58:210-214.
Brandenberger AW, Tee MK, Lee JY, Chao V, Jaffe RB. Tissue distribution of estrogen receptors alpha (ER-α) and beta (ER-ó mRNA in the midgestational human fetus. J Clin Endocrinol Metab 1997;82:3509-3512.
Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinol 1997;138:863-870.
Shupnik MA, Gharib SD, Chin WW. Divergent effects of estradiol on gonadotropin gene transcription in pituitary fragments. Mol Endocrinol 1989;3:474-480.
Chaidarun SS, Eggo MC, Stewart PM, Barber PC, Sheppard MC. Role of growth factors and estrogen as modulators of growth, differentiation, and expression of gonadotropin subunit genes in primary cultured sheep pituitary cells. Endocrinol 1994;134:935-944.
Holmgren U, Bergstrand G, Hagenfeldt K, Werner S. Women with prolactinoma-effect of pregnancy and lactation on serum prolactin and on tumor growth. Acta Endrocrinologica (Copenhagen) 1986;111:452-459.
Gittoes NJL, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA. Thyroid hormone and estrogen receptor expression in normal pituitary and “non-finctioning” tumors of the anterior pituitary. J Clin Endocrinol Metab 1997; 82:1960-1967.
Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
Gittoes NJL, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA. Retinoid X receptor expression in the normal pituitary and clinically non-functioning pituitary tumours. Clin Endocrinol 1998;48:425-434.
Gittoes NJ, McCabe CJ, Verhaeg J, Sheppard MC, Franklyn JA. An abnormality of thyroid hormone receptor expression may explain abnormal thyrotropin production in thyrotropin-secreting pituitary tumors. Thyroid 1998;8:9-14.
Salomon RN, Underwood R, Doyle MV, Wang A, Libby P. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc Natl Acad Sci (USA) 1992;89:2814-2818.
Noonan KE, Beck C, Holzmayer TA, et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci (USA) 1990;87:7160-7164.
Nakayama H, Yokoi H, Fujita J. Quantification of mRNA by non-radioactive RT-PCR and CCD imaging system. Nucleic Acids Res 1992;20:4939.
Alexander JM, Swearingen B, Tindall GT, Klibanski A. Human pituitary adenomas express endogenous inhibin subunit and follistatin messenger ribonucleic acids. J Clin Endocrinol Metab 1995;80:147-152.
Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 1995;80:3621-3627.
Dahia PL, Honegger J, Reincke M. et al. Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors. J Clin EndocrinolMetab 1997;82:1088-1093.
Snyder PJ. 1985 Gonadotroph cell adenomas of the pituitary. [Review]. Endocrin Rev 1985;6:552-563.
Jameson JL, Klibanski A, Black PM et al. Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. J Clin Invest 1987;80:1472-1478.
Klibanski A. Nonsecreting pituitary tumors. [Review]. Endocrinol Metab Clin N Am 1987;16:793-804.
Black PM, Hsu DW, Klibanski A et al. Hormone production in clinically nonfunctioning pituitary adenomas. J Neurosurg 1987;66:244-250.
Warnet A, Porsova-Dutoit I, Lahlou N, Seret-Begue D, Lajeunie E, Chanson P, Woimant F, Lot G, Guillausseau PJ, Roger M. 1994 Glycoprotein hormone alpha-subunit secretion in prolactinomas and in non-functioning adenomas: relation with the tumour size. Clin Endocrinol 41: 177-184.
Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M, Fahlbusch R, Smyth H. 1994 In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J Clin Endocinol Metab 78: 83-88.
Dotzlaw H, Leygue E, Watson PH, Murphy LC. 1997 Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab 82: 2371-2374.
Jazaeri AA, Jazaeri O, Dalton MS, Shupnik MA, Rice LW. 1998 Estrogen receptor beta in normal human endometrium and endometrial carcinoma. Proceedings of the 80th Annual Meeting of the American Endocrine Society, New Orleans, LA. P1-2.
Brandenberger AW, Tee MK, Jaffe RB. 1998 Estrogen receptor alpha (ER-a) and beta (ER-b) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-b in neoplastic tissues. J Clin Endocrinol Metab 83: 1025-1028.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gittoes, N.J., McCabe, C.J., Sheppard, M.C. et al. Estrogen Receptor Beta mRNA Expression in Normal and Adenomatous Pituitaries. Pituitary 1, 99–104 (1999). https://doi.org/10.1023/A:1009928420333
Issue Date:
DOI: https://doi.org/10.1023/A:1009928420333